A universal reporter cell line for bioactivity evaluation of engineered cytokine products.
Ontology highlight
ABSTRACT: Engineered cytokine products represent a growing class of therapeutic proteins which need to be tested for biological activity at various stages of pharmaceutical development. In most cases, dedicated biological assays are established for different products, in a process that can be time-consuming and cumbersome. Here we describe the development and implementation of a universal cell-based reporter system for various classes of immunomodulatory proteins. The novel system capitalizes on the fact that the signaling of various types of pro-inflammatory agents (e.g., cytokines, chemokines, Toll-like receptor agonists) may involve transcriptional activation by NF-κB. Using viral transduction, we generated stably-transformed cell lines of B or T lymphocyte origin and compared the new reporter ce
SUBMITTER: Mock J
PROVIDER: S-EPMC7040017 | biostudies-literature | 2020 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA